Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
NXT2B AB is a privately owned venture capital firm founded in 2011 by Swedish entrepreneur Bengt Ågerup. The firm is headquartered in Uppsala, Sweden, and has established itself as a key player in the growth equity investment space. NXT2B focuses primarily on sectors such as healthcare, medical devices, specialty pharmaceuticals, technology, and consumer products. Since its inception, the firm has invested in over 30 companies, demonstrating a strong commitment to supporting innovative ventures.
Over the years, NXT2B has built a diverse portfolio that reflects its investment philosophy of targeting early-phase projects with high scientific quality and viable business opportunities. The firm operates primarily within Europe, leveraging its regional expertise to identify promising startups. Notable milestones include the successful backing of several companies that have made significant advancements in their respective fields.
NXT2B specializes in growth equity investments across several key sectors, including healthcare, medical devices, specialty pharmaceuticals, technology, and consumer products. The firm is particularly interested in early-phase projects that exhibit high scientific quality and reasonable business opportunities. This focus allows NXT2B to identify and support companies that are not only innovative but also have the potential for substantial market impact.
The investment strategy emphasizes a thorough evaluation of scientific merit and business viability, ensuring that the selected projects align with NXT2B's high standards. The firm typically engages in investments that provide the necessary capital for growth while also offering strategic guidance to portfolio companies. NXT2B's geographic focus is primarily on Europe, where it seeks to capitalize on emerging trends and technologies.
NXT2B AB has a diverse portfolio of notable companies, reflecting its investment strategy in high-potential sectors. Key portfolio companies include:
This portfolio showcases NXT2B's commitment to investing in companies that are at the forefront of scientific and technological advancements.
Bengt Ågerup - Founder and Entrepreneur. Bengt has extensive experience in the venture capital space and has led numerous successful investments in the healthcare sector.
Erika Kjellberg Eriksson - CEO and Chair of the Board. Erika brings a wealth of knowledge in strategic management and has been instrumental in guiding NXT2B's investment strategy.
Per-Olof Wallström - Member of the Board. Per-Olof has a strong background in finance and investment, contributing to the firm's decision-making processes.
Angelica Loskog - Scientific Adviser. Angelica provides critical insights into the scientific aspects of potential investments, ensuring that NXT2B maintains its high standards for scientific quality.
To pitch NXT2B, founders should send an email to info@nxt2b.com. A concise pitch deck that includes key information about the business model, market opportunity, and scientific basis is essential. Response times may vary, but founders can expect to hear back within a few weeks.
In recent months, NXT2B AB has continued to expand its portfolio, adding several innovative companies in the healthcare and technology sectors. The firm remains active in identifying promising early-phase projects that align with its investment thesis. Specific details about recent investments or exits have not been disclosed, but the firm is known for its strategic approach to growth equity.
What are NXT2B's investment criteria?
NXT2B focuses on growth equity investments in early-phase projects that demonstrate high scientific quality and viable business opportunities. The firm seeks companies in healthcare, medical devices, specialty pharmaceuticals, technology, and consumer sectors.
How can I apply or pitch to NXT2B?
Founders can reach out to NXT2B via email at info@nxt2b.com to discuss potential investment opportunities. A well-prepared pitch deck that outlines the business model, market potential, and scientific merit is recommended.
What makes NXT2B different from other venture capital firms?
NXT2B distinguishes itself by its strong focus on scientific quality and its commitment to supporting early-phase projects. The firm combines financial investment with strategic guidance to help portfolio companies achieve their growth objectives.
What is the geographic scope of NXT2B's investments?
NXT2B primarily invests in companies based in Europe, leveraging its regional expertise to identify promising startups and innovative technologies.
What is the typical check size for investments?
While specific check sizes are not disclosed, NXT2B focuses on growth equity investments, which typically involve significant capital to support the scaling of early-phase projects.
What kind of post-investment involvement does NXT2B have?
NXT2B actively engages with its portfolio companies, providing strategic guidance and support to help them navigate challenges and capitalize on growth opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.